Given Imaging gets Bravo from Medtronic
This article was originally published in The Gray Sheet
Executive Summary
Given Imaging acquires Medtronic's Bravo wireless gastroesophageal reflux disease monitor business for $20 million Dec. 8. The catheter-free GERD test, which uses a disposable capsule temporarily placed in the esophagus to measure pH levels and transmit data to an external receiver, will add about $12 million to Given's sales in 2009, the firm predicts. Bravo "is a synergistic and strategic fit" with Given's PillCam video capsule-based diagnostic system for gastrointestinal disorders, according to the company